BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34116210)

  • 1. The novel FAT4 activator jujuboside A suppresses NSCLC tumorigenesis by activating HIPPO signaling and inhibiting YAP nuclear translocation.
    Wang W; Huang Q; Chen Y; Huang Z; Huang Y; Wang Y; Qi X; Liu Z; Lu L
    Pharmacol Res; 2021 Aug; 170():105723. PubMed ID: 34116210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ethyl acetate extract from Celastrus orbiculatus suppresses non-small-cell lung cancer by activating Hippo signaling and inhibiting YAP nuclear translocation.
    Jin F; Ni X; Yu S; Jiang X; Shi X; Zhou J; Mao D; Wang H; Liu Y; Wu F
    Phytomedicine; 2023 Jun; 114():154761. PubMed ID: 37028249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of FAT4 suppress metastasis of lung adenocarcinoma through regulating MAPK pathway and associated with immune cells infiltration.
    Ning Y; Yang Y; Zheng H; Zhan Y; Zang H; Wen Q; Peng J; Fan S
    Cancer Med; 2023 Jan; 12(2):1616-1629. PubMed ID: 35770846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fat4 suppression induces Yap translocation accounting for the promoted proliferation and migration of gastric cancer cells.
    Ma L; Cui J; Xi H; Bian S; Wei B; Chen L
    Cancer Biol Ther; 2016; 17(1):36-47. PubMed ID: 26575609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA NSCLCAT1 increases non-small cell lung cancer cell invasion and migration through the Hippo signaling pathway by interacting with CDH1.
    Zhao W; Zhang LN; Wang XL; Zhang J; Yu HX
    FASEB J; 2019 Jan; 33(1):1151-1166. PubMed ID: 30148675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
    Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
    Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway.
    Li SY; Wang H; Mai HF; Li GF; Chen SJ; Li GS; Liang BC
    Cancer Gene Ther; 2019 Nov; 26(11-12):374-387. PubMed ID: 30546116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Air pollution-regulated E-cadherin mediates contact inhibition of proliferation via the hippo signaling pathways in emphysema.
    Chang JH; Lee YL; Laiman V; Han CL; Jheng YT; Lee KY; Yeh CT; Kuo HP; Chung KF; Heriyanto DS; Hsiao TC; Wu SM; Ho SC; Chuang KJ; Chuang HC
    Chem Biol Interact; 2022 Jan; 351():109763. PubMed ID: 34852269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyphyllin VI, a saponin from Trillium tschonoskii Maxim. induces apoptotic and autophagic cell death via the ROS triggered mTOR signaling pathway in non-small cell lung cancer.
    Teng JF; Qin DL; Mei QB; Qiu WQ; Pan R; Xiong R; Zhao Y; Law BY; Wong VK; Tang Y; Yu CL; Zhang F; Wu JM; Wu AG
    Pharmacol Res; 2019 Sep; 147():104396. PubMed ID: 31404628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aqueous extract of Taxus chinensis var. mairei regulates the Hippo-YAP pathway and promotes apoptosis of non-small cell lung cancer via ATF3 in vivo and in vitro.
    Zhang G; Dai S; Chen Y; Wang H; Chen T; Shu Q; Chen S; Shou L; Cai X
    Biomed Pharmacother; 2021 Jun; 138():111506. PubMed ID: 33740524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer.
    Malgundkar SH; Burney I; Al Moundhri M; Al Kalbani M; Lakhtakia R; Okamoto A; Tamimi Y
    BMC Cancer; 2020 May; 20(1):374. PubMed ID: 32366234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traditional Chinese medicine Ze-Qi-Tang formula inhibit growth of non-small-cell lung cancer cells through the p53 pathway.
    Xu Z; Zhang F; Zhu Y; Liu F; Chen X; Wei L; Zhang N; Zhou Q; Zhong H; Yao C; Zhu X; Gong C; Zhu S; Zou C
    J Ethnopharmacol; 2019 Apr; 234():180-188. PubMed ID: 30660711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells.
    You B; Yang YL; Xu Z; Dai Y; Liu S; Mao JH; Tetsu O; Li H; Jablons DM; You L
    Oncotarget; 2015 Feb; 6(6):4357-68. PubMed ID: 25738359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAT4 activation inhibits epithelial-mesenchymal transition (EMT) by promoting autophagy in H2228/Cer cells.
    Yang Y; Li Y; Yang Q; Liu Z; Chang X; Yang H; Liu J; Li Z; Zuo D
    Med Oncol; 2022 Dec; 40(1):64. PubMed ID: 36576661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibin βA is an independent prognostic factor that promotes invasion via Hippo signaling in non‑small cell lung cancer.
    Zhang Y; Yan S; Li Y; Zhang J; Luo Y; Li P; Yang Y; Li Y; Huang Y; Wang E
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34505633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cucurbitacin E inhibits the Yes‑associated protein signaling pathway and suppresses brain metastasis of human non‑small cell lung cancer in a murine model.
    Hsu PC; Tian B; Yang YL; Wang YC; Liu S; Urisman A; Yang CT; Xu Z; Jablons DM; You L
    Oncol Rep; 2019 Aug; 42(2):697-707. PubMed ID: 31233205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway.
    Wu T; Hu H; Zhang T; Jiang L; Li X; Liu S; Zheng C; Yan G; Chen W; Ning Y; Li Y; Lu Z
    Oxid Med Cell Longev; 2019; 2019():9719723. PubMed ID: 31316723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evodiamine suppresses Notch3 signaling in lung tumorigenesis via direct binding to γ-secretases.
    Yang X; Zhang Y; Huang Y; Wang Y; Qi X; Su T; Lu L
    Phytomedicine; 2020 Mar; 68():153176. PubMed ID: 32045841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rottlerin exhibits antitumor activity via down-regulation of TAZ in non-small cell lung cancer.
    Zhao Z; Zheng N; Wang L; Hou Y; Zhou X; Wang Z
    Oncotarget; 2017 Jan; 8(5):7827-7838. PubMed ID: 27999199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of Non-Small Cell Lung Cancer Growth and Metastasis by a Novel Small Molecular Activator of RECK.
    Shen J; Wang B; Zhang T; Zhu N; Wang Z; Jin J; He Y; Hu M
    Cell Physiol Biochem; 2018; 45(5):1807-1817. PubMed ID: 29510387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.